A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury

NCT00407745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuralgia
Spinal Cord Injuries

Interventions

DRUG: placebo
DRUG: pregabalin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.